Advertisement
Obstetrics/Gynecology
Subscribe to Obstetrics/Gynecology
View Sample

FREE Email Newsletter

May is Older Americans Month

May 3, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

WILMINGTON, N.C., May 3, 2011 /- Former president John F. Kennedy designated the month of May as Older Americans Month in 1963 and it has since become a long-standing tradition to pay tribute to older adults. At that time, only 17 million Americans had reached their 65th birthday,...

Making Childbirth Safer

April 27, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

ATLANTA, April 27, 2011 /- Trig Medical, Inc. announces the U.S. launch of LaborPro®, the new standard for labor progression management, at the American Congress of Obstetricians and Gynecologists (ACOG) 2011 Annual Clinical Meeting, taking place April 30 – May 4, 2011 in...

Ferring Celebrates Winners of 2010 My Little Miracle Essay Contest During National Infertility Awareness Week

April 25, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., April 25, 2011 /- Celebrating National Infertility Awareness Week, April 24-30, 2011, Ferring Pharmaceuticals Inc. is honoring three lucky families who won its 2010 My Little Miracle Essay Contest for their inspirational stories about overcoming their struggle with...

Advertisement

Clinical Studies Results of Uroplasty Products Scheduled for Presentation at Three Professional Meetings

April 25, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

MINNETONKA, Minn., April 25, 2011 /- Uroplasty, Inc. (NASDAQ: UPI ), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that the results of clinical studies using Uroplasty's Urgent® PC...

Smith & Nephew Endoscopy unit marks medical device milestone

April 6, 2011 9:36 am | by Mass High Tech: The Journal of New England Technology | News | Comments

The Andover-based Endoscopy division of Smith & Nephew plc, a medical devices firm with headquarters in London, has had its flagship product, the TRUCLEAR System, hit 30,000 procedures.

Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results

April 6, 2011 6:37 am | by Bio-Medicine.Org | News | Comments

LIVINGSTON, N.J. and MORRISTOWN, N.J., April 6, 2011 /- Columbia Laboratories, Inc. (Nasdaq: CBRX ), and Watson Pharmaceuticals, Inc. (NYSE: WPI ), today announced the publication of Phase III PROCHIEVE® (progesterone gel) data in today's online version of Ultrasound in Obstetrics...

IBM Helps Bring Smarter Healthcare to Nigeria's Cross River State

April 6, 2011 2:34 am | by IBM | News | Comments

Ahead of World Health Day, IBM (NYSE: IBM) announced details of its involvement with two government programs in Cross River State, Nigeria aimed at providing access to free healthcare and alleviating poverty. E-mail this page Save to del.icio.us Digg this

Eisenhower Medical Center Reports Theft of Computer and Television

March 30, 2011 7:36 am | by Bio-Medicine.Org | News | Comments

RANCHO MIRAGE, Calif., March 30, 2011 /- Eisenhower Medical Center (EMC) has implemented additional security procedures and protocols to help ensure patient privacy and security after a hospital computer and a television were stolen in a burglary on Friday, March 11. The computer was...

Advertisement

TV Personality Vanessa Minnillo Teams Up With Bayer and March of Dimes to Launch National Folate Awareness Campaign

March 15, 2011 7:37 am | by Bio-Medicine.Org | News | Comments

WHITE PLAINS, N.Y. and WAYNE, N.J., March 15, 2011 /- Vanessa Minnillo is making it a priority to share an important public health message with women nationwide. Minnillo is working with March of Dimes® and Bayer HealthCare Pharmaceuticals to help educate all women of reproductive...

OVA1 Included in Latest ACOG/SGO Committee Opinion

March 14, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, March 14, 2011 /- (Nasdaq: VRML ) –Vermillion, a molecular diagnostics company, announced today the inclusion of OVA1® as part of the recently published ACOG/SGO committee opinion. In the March edition of Obstetrics and Gynecology , the American College of...

K-V Pharmaceutical Company Announces Comprehensive Patient Assistance Program for Makenaâ„¢

March 8, 2011 7:34 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, March 8, 2011 /- K-V Pharmaceutical Company (NYSE: KVa/KVb) (the "Company"), a specialty pharmaceutical company, along with its branded subsidiary, Ther-Rx Corporation, today announced the details of its patient assistance program for Makena ™ -eligible patients....

FDA Approves Makenaâ„¢, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm ...

February 4, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Feb. 4, 2011 /- K-V Pharmaceutical Company (NYSE: KVa/KVb) (the "Company"), a specialty pharmaceutical company, announced today that it has been informed by Hologic, Inc. that the U.S. Food and Drug Administration (FDA) granted approval for Makena™ (hydroxyprogesterone...

FDA Approves Drug to Reduce Risk of Preterm Birth in At-Risk Pregnant Women

February 4, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Feb. 4, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery before 37 weeks of pregnancy, in pregnant women with a history of at least one...

Advertisement

FDA Approves Hologic's Makenaâ„¢ (Formerly Referred to as Gestivaâ„¢) Pharmaceutical

February 4, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

BEDFORD, Mass., Feb. 4, 2011 /- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX ), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the...

VIVUS Provides Regulatory Update on QNEXA NDA

January 21, 2011 3:36 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Jan. 21, 2011 /- VIVUS, Inc. (Nasdaq: VVUS ) today announced that it held an End-of-Review meeting with the Food and Drug Administration (FDA) for the New Drug Application (NDA) for QNEXA®, an investigational drug for the treatment of obesity.  The meeting...

Accuray Hires Chief Marketing Officer

January 18, 2011 5:39 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Jan. 18, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that Eric Pauwels has joined Accuray as Senior Vice President and Chief Marketing Officer, effective January 17, 2011. Pauwels is a global industry...

Reportlinker Adds Germany Pharmaceutical Market Overview - New pricing rules set to negatively impact drug sales both domestically and internationally

January 11, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Jan. 11, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Germany Pharmaceutical Market Overview – New pricing rules set to negatively impact drug sales both domestically and internationally...

Reportlinker Adds France Pharmaceutical Market Overview - Austerity measures will impact pharmaceutical market growth

January 11, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Jan. 11, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: France Pharmaceutical Market Overview – Austerity measures will impact pharmaceutical market growth...

Decades-Long Medical Study Begins With Kickoff

January 10, 2011 10:35 pm | by San Diego Business Journal | News | Comments

The San Diego County component of the nation's largest long-term examination of children's health and development was launched Jan. 10.

Sharp and Kaiser Are Putting Big Construction Plans Into Action

January 9, 2011 10:35 pm | by San Diego Business Journal | News | Comments

Construction projects planned by two local health care systems are promising to bring a major economic stimulus jolt to the San Diego region this year.

Viveve Obtains CE Mark for Gynecologic Treatment of Vaginal Laxity

January 6, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., Jan. 6, 2011 /- Viveve, Inc. , a development stage women's health company, announced today that it has received the European CE (Conformite Europeenne) mark for the use of its Viveve System for the non-surgical treatment of laxity of the vaginal introitus (opening),...

Sequenom CMM Commences Pivotal Clinical Validation Study for Its SensiGene Trisomy 21 Laboratory Developed Test(2)

December 22, 2010 5:34 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Dec. 22, 2010 /- Sequenom, Inc. (Nasdaq: SQNM ) today announced that the company's wholly-owned reference laboratory, the Sequenom Center for Molecular Medicine (Sequenom CMM), has authorized commencement of a pivotal clinical validation study. This validation study is designed...

Investors eye shift in Boston life sciences funding

December 21, 2010 7:35 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

Venture capital may be playing a less important role in the region's biotech industry, while big pharma may be playing as important a role as VC, as a strategic investor to fund drug development, and as an eventual acquirer. Investors also point to more Boston-area activity by big pharma...

INVO Bioscience Announces First Shipments of INVOcell Into Bolivia

December 21, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

BEVERLY, Mass., Dec. 21, 2010 /- INVO Bioscience, Inc. (OTC Bulletin Board: IVOB ), a medical device company focused on treatment options for patients diagnosed with infertility, today announced the initial shipments of the INVOcell device into Bolivia.  The initial order of INVOcell...

Stem Cells Made with RNA

December 20, 2010 8:34 pm | by Massachusetts Institute of Technology | News | Comments

A new technique could provide safer cells for human therapies

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading